Voice J K, Lachmann P J
Molecular Immunopathology Unit, MRC Center, Cambridge, GB.
Eur J Immunol. 1997 Oct;27(10):2514-23. doi: 10.1002/eji.1830271008.
We examined the effect of soluble IgG immune complex (IC) characteristics on the binding of IC to human neutrophils and IC-induced specific granule release of neutrophils via Fc gamma receptors (CD16 and CD32) and complement receptors (CR1 and CR3). A set of soluble IgG IC varying in size, IgG subclass, antigen epitope density and complement (C) incorporation were formed between 5-iodo-4-hydroxy-3-nitrophenacetyl (NIP) coupled to bovine serum albumin (BSA) and chimeric mouse-human anti-NIP monoclonal antibodies (mAb) of all four IgG subclasses. High and low epitope density IC of all four IgG subclasses induced specific granule release with C, but in the absence of C only IgG1 and IgG3 IC were functionally active. The Fc gamma and C receptors responsible for IgG IC-induced specific granule release and IC binding were determined using mAb specific for the ligand binding sites of CD16, CD32 and CR3, and recombinant soluble CR1. Each defined IC displayed a unique pattern of receptor preference, dependent upon subclass and antigenic epitope density. IC binding and IC-induced specific granule release was not mediated by the same receptor, or combination of receptors. High and low epitope density IgG3 IC binding and induction of specific granule release was mediated predominantly via CD16. Other IC subclasses bound differently, i.e. IgG1 IC used CD16 and CR3; IgG2 and IgG4 predominantly used complement receptors; but all three induced specific granule release via CD32. In vivo these results may translate into differential activation of neutrophils by soluble IC dependent upon their characteristics, leading to subtle nuances in the etiology, pathology and control of the immune response in IC-related diseases.
我们研究了可溶性IgG免疫复合物(IC)特性对IC与人中性粒细胞结合以及IC通过Fcγ受体(CD16和CD32)和补体受体(CR1和CR3)诱导中性粒细胞特异性颗粒释放的影响。在与牛血清白蛋白(BSA)偶联的5-碘-4-羟基-3-硝基苯乙酰(NIP)和所有四种IgG亚类的嵌合鼠-人抗NIP单克隆抗体(mAb)之间形成了一组大小、IgG亚类、抗原表位密度和补体(C)掺入量不同的可溶性IgG IC。所有四种IgG亚类的高表位密度和低表位密度IC均可诱导C依赖性特异性颗粒释放,但在无C的情况下,只有IgG1和IgG3 IC具有功能活性。使用针对CD16、CD32和CR3配体结合位点的mAb以及重组可溶性CR1,确定了负责IgG IC诱导的特异性颗粒释放和IC结合的Fcγ和C受体。每种确定的IC都表现出独特的受体偏好模式,这取决于亚类和抗原表位密度。IC结合和IC诱导的特异性颗粒释放不是由相同的受体或受体组合介导的。高表位密度和低表位密度IgG3 IC的结合以及特异性颗粒释放的诱导主要通过CD16介导。其他IC亚类的结合方式不同,即IgG1 IC使用CD16和CR3;IgG2和IgG4主要使用补体受体;但所有三种亚类均通过CD32诱导特异性颗粒释放。在体内,这些结果可能转化为可溶性IC根据其特性对中性粒细胞的差异性激活,从而导致IC相关疾病免疫反应的病因、病理和控制方面的细微差别。